Mortality in ovarian cancer is predominantly due to acquired chemoresistance and tumor recurrence. UBIQUITIN CONJUGATING ENZYME E2 or RAD6 expression increases in cell lines and patient tumors in response to platinum-based chemotherapy and promotes both activation of DNA damage response pathways and expression of stemness genes and a stem cell-like phenotype driving ovarian cancer chemoresistance.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791863 | PMC |
| http://dx.doi.org/10.1080/23723556.2017.1392403 | DOI Listing |
Publication Analysis
Top Keywords
ovarian cancer
12
rad6 promotes
4
promotes chemoresistance
4
chemoresistance ovarian
4
cancer mortality
4
mortality ovarian
4
cancer acquired
4
acquired chemoresistance
4
chemoresistance tumor
4
tumor recurrence
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!